TRLS-03 - Phase II Trial of GDC-0084 in combination with Trastuzumab for Patients with HER2-Positive Breast Cancer Brain Metastases (BCBM)
Friday, August 16
5:30 PM - 7:30 PM
Location: Empire Ballroom
Presenting Author(s)
- JL
Jose Pablo Leone
https://www.eventscribe.com/2019/BrainMets/aaStatic.asp?SFP=Vk5QRlFIUllAMjIzMQ